MGMT-Methylated Glioblastoma — Trials

MGMT-Methylated Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 5
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Baptist Health South Florida
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06095375	Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients(REGOMA-2)	completed	Phase 1	21	Istituto Oncologico Veneto IRCCSOTHER	1	Jan 9, 2026	clinicaltrials

Data updated 22 days agoSource updated Jan 9, 2026source: clinicaltrials